Main Article Content

Assessment of Pro Collagen III as Non-Invasive Biomarker for Diagnosis of Non-Alcoholic Steatohepatitis


Esam Abdel-aty Ahmed Ashoush
Hanan Mahmoud Badawy
Ahmed Samir Allam
Salah Sharawy Galal

Abstract

Background: One of the most frequent causes of chronic liver disease globally is non-alcoholic fatty liver disease (NAFLD). It is believed  that NAFLD is the hepatic expression of metabolic syndrome. Historically, NAFLD was thought to be a rather benign liver condition.  Hepatocellular carcinoma, cirrhosis, and liver fibrosis can develop in some NAFLD patients. Consequently, it is crucial from a clinical  standpoint to accurately diagnose and stage NAFLD patients.


Objective: This study aimed to evaluate the performance of pro collagen III as a NASH-Fibrosis biomarker within the optimum diagnostic  context of usage in comparison with FIB-4.


Patients and Methods: This study was a case-control study that was conducted at  Gastroenterology and Hepatology Outpatient Clinic at Damas Centre for Liver and GIT. This study was performed on 56 Egyptian patients  who were ≥ 18 years of age and are overweight with Body Mass Index ≥ 25 and diagnosed with NAFLD by US. They were divided into 2  groups: Group 1 included 28 healthy individuals diagnosed with NAFLD by US without any evidence of hepatitis and group II that included  28 patients with NASH diagnosed by elevated liver enzymes.


Results: Patients with non-alcoholic steatohepatitis (NASH) have  relatively low platelet count in comparison with NAFLD patients. Patients with NASH had Higher AST & ALT levels than NAFLD patients.  FIB-4 was higher in NASH group than NAFLD group. Pro collagen III level was higher in patients with NASH than patients with NAFLD. Pro  collagen III was a significant discriminator of NAFLD & NASH. Pro collagen III correlates with the grades of histological steatohepatitis,  and stage of fibrosis. Pro collagen III can diagnose steatohepatitis at cut-off 9.57 with sensitivity & specificity was 92.9% & 92.9%  respectively.


Conclusion: Pro collagen III is a sensitive biomarker to discriminate between NAFLD & NASH. Pro collagen III level correlate  positively with BMI, AST & ALT. Pro collagen III level correlate with grades of histological steatohepatitis and grades of fibrosis.    


Journal Identifiers


eISSN: 2090-7125
print ISSN: 1687-2002